Company page

Medigen Vaccine Biologics Corp.

Medigen Vaccine Biologics Corp. is a publicly traded company on the Taiwan stock market under the ticker 6547. The company has a market capitalization of approximately NT$498.71 million. Medigen focuses on the development and production of vaccines, contributing to public health initiatives.

profile6547AI content: aiUpdated May 26, 2026/company/medigen-vaccine-biologics-corp
Medigen Vaccine Biologics Corp. logo
Ticker
6547
Market cap
$498.7M
Sector
Health Technology
Industry
Biotechnology